Ubigene Highlights Gene Knockout Cell Line Capabilities to Help Accelerate Research Efficiency

EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
PharmiWeb

PlasmidFactory’s Minicircle DNA: Raising the Bar in Gene and Cell Therapy

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
C&EN

Heparin Enhances Transfection in Concert with a Trehalose-Based Polycation with Challenging Cell Types

† Department of Chemistry and ‡ Stem Cell Institute and Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota, United States Article Views are the ...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Transient but transformative: Sanofi’s mRNA CAR-T enters in vivo race

In a recent article in Molecular Therapy, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T ...
Nanowerk

Silicon nanotube arrays deliver mRNA into human stem cells while preserving pluripotency

Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.